Cargando…
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472701/ https://www.ncbi.nlm.nih.gov/pubmed/36083126 http://dx.doi.org/10.1182/bloodadvances.2022008375 |
| _version_ | 1784789350821658624 |
|---|---|
| author | Harrington, Patrick Kurshan, Ashwini Delord, Marc Lechmere, Thomas Sheikh, Amna Saunders, Jamie Saha, Chandan Dillon, Richard Woodley, Claire Asirvatham, Susan Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Radia, Deepti McLornan, Donal Malim, Michael H. Harrison, Claire Doores, Katie J. de Lavallade, Hugues |
| author_facet | Harrington, Patrick Kurshan, Ashwini Delord, Marc Lechmere, Thomas Sheikh, Amna Saunders, Jamie Saha, Chandan Dillon, Richard Woodley, Claire Asirvatham, Susan Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Radia, Deepti McLornan, Donal Malim, Michael H. Harrison, Claire Doores, Katie J. de Lavallade, Hugues |
| author_sort | Harrington, Patrick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9472701 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94727012022-09-14 Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders Harrington, Patrick Kurshan, Ashwini Delord, Marc Lechmere, Thomas Sheikh, Amna Saunders, Jamie Saha, Chandan Dillon, Richard Woodley, Claire Asirvatham, Susan Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Radia, Deepti McLornan, Donal Malim, Michael H. Harrison, Claire Doores, Katie J. de Lavallade, Hugues Blood Adv Research Letter The American Society of Hematology 2022-09-14 /pmc/articles/PMC9472701/ /pubmed/36083126 http://dx.doi.org/10.1182/bloodadvances.2022008375 Text en © 2023 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Harrington, Patrick Kurshan, Ashwini Delord, Marc Lechmere, Thomas Sheikh, Amna Saunders, Jamie Saha, Chandan Dillon, Richard Woodley, Claire Asirvatham, Susan Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Radia, Deepti McLornan, Donal Malim, Michael H. Harrison, Claire Doores, Katie J. de Lavallade, Hugues Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title | Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title_full | Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title_fullStr | Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title_full_unstemmed | Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title_short | Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders |
| title_sort | third-dose sars-cov-2 mrna vaccine increases omicron variant neutralization in patients with chronic myeloid disorders |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472701/ https://www.ncbi.nlm.nih.gov/pubmed/36083126 http://dx.doi.org/10.1182/bloodadvances.2022008375 |
| work_keys_str_mv | AT harringtonpatrick thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT kurshanashwini thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT delordmarc thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT lechmerethomas thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT sheikhamna thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT saundersjamie thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT sahachandan thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT dillonrichard thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT woodleyclaire thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT asirvathamsusan thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT curtogarcianatalia thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT sullivanjennifero thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT kordastishahram thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT radiadeepti thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT mclornandonal thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT malimmichaelh thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT harrisonclaire thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT dooreskatiej thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders AT delavalladehugues thirddosesarscov2mrnavaccineincreasesomicronvariantneutralizationinpatientswithchronicmyeloiddisorders |